Literature DB >> 30988160

Growth Factor Independence 1B-Mediated Transcriptional Repression and Lineage Allocation Require Lysine-Specific Demethylase 1-Dependent Recruitment of the BHC Complex.

David McClellan1, Mattie J Casey1, Diana Bareyan1, Helena Lucente1, Christopher Ours2,3, Matthew Velinder4, Jason Singer4, Mehraju Din Lone1, Wenxiang Sun1, Yunuen Coria1, Clinton C Mason2,3, Michael E Engel5,2,3,6,7.   

Abstract

Growth factor independence 1B (GFI1B) coordinates assembly of transcriptional repressor complexes comprised of corepressors and histone-modifying enzymes to control gene expression programs governing lineage allocation in hematopoiesis. Enforced expression of GFI1B in K562 erythroleukemia cells favors erythroid over megakaryocytic differentiation, providing a platform to define molecular determinants of binary fate decisions triggered by GFI1B. We deployed proteome-wide proximity labeling to identify factors whose inclusion in GFI1B complexes depends upon GFI1B's obligate effector, lysine-specific demethylase 1 (LSD1). We show that GFI1B preferentially recruits core and putative elements of the BRAF-histone deacetylase (HDAC) (BHC) chromatin-remodeling complex (LSD1, RCOR1, HMG20A, HMG20B, HDAC1, HDAC2, PHF21A, GSE1, ZMYM2, and ZNF217) in an LSD1-dependent manner to control acquisition of erythroid traits by K562 cells. Among these elements, depletion of both HMG20A and HMG20B or of GSE1 blocks GFI1B-mediated erythroid differentiation, phenocopying impaired differentiation brought on by LSD1 depletion or disruption of GFI1B-LSD1 binding. These findings demonstrate the central role of the GFI1B-LSD1 interaction as a determinant of BHC complex recruitment to enable cell fate decisions driven by GFI1B.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  BHC complex; Erythropoiesis; GFI1B; GSE1; HMG20A; HMG20B; LSD1; SNAG domain; hematopoiesis; transcriptional repression

Mesh:

Substances:

Year:  2019        PMID: 30988160      PMCID: PMC6580704          DOI: 10.1128/MCB.00020-19

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  95 in total

1.  A short Gfi-1B isoform controls erythroid differentiation by recruiting the LSD1-CoREST complex through the dimethylation of its SNAG domain.

Authors:  Benoît Laurent; Voahangy Randrianarison-Huetz; Emilie Frisan; Charlotte Andrieu-Soler; Eric Soler; Michaela Fontenay; Isabelle Dusanter-Fourt; Dominique Duménil
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

2.  GFI1B controls its own expression binding to multiple sites.

Authors:  Eduardo Anguita; Ana Villegas; Francisco Iborra; Aurora Hernández
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

3.  The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1.

Authors:  Yiwei Lin; Yadi Wu; Junlin Li; Chenfang Dong; Xiaofeng Ye; Young-In Chi; B Mark Evers; Binhua P Zhou
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

4.  Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.

Authors:  M Zörnig; T Schmidt; H Karsunky; A Grzeschiczek; T Möröy
Journal:  Oncogene       Date:  1996-04-18       Impact factor: 9.867

5.  Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1.

Authors:  Holger Karsunky; Hui Zeng; Thorsten Schmidt; Branko Zevnik; Reinhart Kluge; Kurt Werner Schmid; Ulrich Dührsen; Tarik Möröy
Journal:  Nat Genet       Date:  2002-01-28       Impact factor: 38.330

6.  Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.

Authors:  Jun Xia; Audrey A Bolyard; Elin Rodger; Steve Stein; Andrew A Aprikyan; David C Dale; Daniel C Link
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

7.  SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.

Authors:  Daniel Andrade; Matthew Velinder; Jason Singer; Luke Maese; Diana Bareyan; Hong Nguyen; Mahesh B Chandrasekharan; Helena Lucente; David McClellan; David Jones; Sunil Sharma; Fang Liu; Michael E Engel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

Review 8.  The high mobility group box: the ultimate utility player of a cell.

Authors:  Christopher S Malarkey; Mair E A Churchill
Journal:  Trends Biochem Sci       Date:  2012-11-13       Impact factor: 13.807

Review 9.  Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Authors:  Andrew P Feinberg; Michael A Koldobskiy; Anita Göndör
Journal:  Nat Rev Genet       Date:  2016-03-14       Impact factor: 53.242

10.  Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.

Authors:  Giacomo Volpe; David S Walton; David E Grainger; Carl Ward; Pierre Cauchy; Daniel Blakemore; Daniel J L Coleman; Peter N Cockerill; Paloma Garcia; Jon Frampton
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

View more
  13 in total

1.  Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.

Authors:  Lama AlAbdi; Debapriya Saha; Ming He; Mohd Saleem Dar; Sagar M Utturkar; Putu Ayu Sudyanti; Stephen McCune; Brice H Spears; James A Breedlove; Nadia A Lanman; Humaira Gowher
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

2.  A human cell atlas of fetal chromatin accessibility.

Authors:  Silvia Domcke; Andrew J Hill; Riza M Daza; Junyue Cao; Diana R O'Day; Hannah A Pliner; Kimberly A Aldinger; Dmitry Pokholok; Fan Zhang; Jennifer H Milbank; Michael A Zager; Ian A Glass; Frank J Steemers; Dan Doherty; Cole Trapnell; Darren A Cusanovich; Jay Shendure
Journal:  Science       Date:  2020-11-13       Impact factor: 47.728

3.  HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.

Authors:  Alba Maiques-Diaz; Luciano Nicosia; Naseer J Basma; Isabel Romero-Camarero; Francesco Camera; Gary J Spencer; Fabio M R Amaral; Fabrizio Simeoni; Bettina Wingelhofer; Andrew J K Williamson; Andrew Pierce; Anthony D Whetton; Tim C P Somervaille
Journal:  Oncogene       Date:  2022-09-28       Impact factor: 8.756

4.  GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia.

Authors:  Wenxiang Sun; Jingtao Guo; David McClellan; Alexandra Poeschla; Diana Bareyan; Mattie J Casey; Bradley R Cairns; Dean Tantin; Michael E Engel
Journal:  Mol Cancer Res       Date:  2022-04-01       Impact factor: 6.333

Review 5.  Proximity-dependent labeling methods for proteomic profiling in living cells: An update.

Authors:  Justin A Bosch; Chiao-Lin Chen; Norbert Perrimon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2020-09-10       Impact factor: 5.814

Review 6.  'Enhancing' red cell fate through epigenetic mechanisms.

Authors:  Marlies P Rossmann; Leonard I Zon
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

7.  Proximity labeling in mammalian cells with TurboID and split-TurboID.

Authors:  Kelvin F Cho; Tess C Branon; Namrata D Udeshi; Samuel A Myers; Steven A Carr; Alice Y Ting
Journal:  Nat Protoc       Date:  2020-11-02       Impact factor: 13.491

Review 8.  Proximity Labeling Techniques to Study Chromatin.

Authors:  Henning Ummethum; Stephan Hamperl
Journal:  Front Genet       Date:  2020-05-12       Impact factor: 4.599

Review 9.  Targeting the GFI1/1B-CoREST Complex in Acute Myeloid Leukemia.

Authors:  Maaike G J M van Bergen; Bert A van der Reijden
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

Review 10.  Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability.

Authors:  Giorgio Milazzo; Daniele Mercatelli; Giulia Di Muzio; Luca Triboli; Piergiuseppe De Rosa; Giovanni Perini; Federico M Giorgi
Journal:  Genes (Basel)       Date:  2020-05-15       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.